Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Nov 21;29(4):232-234.
doi: 10.4103/meajo.meajo_118_22. eCollection 2022 Oct-Dec.

Limbal Autograft Stem Cell Transplantation: More Than 20-Year Follow-up

Affiliations
Case Reports

Limbal Autograft Stem Cell Transplantation: More Than 20-Year Follow-up

Saeed A Al-Motowa et al. Middle East Afr J Ophthalmol. .

Abstract

Limbal stem cell deficiency (LSCD) is a very challenging situation and difficult to manage. A great works and ideas were conducted over the past 50 years. Numerous surgical techniques were proposed. We are reporting more than a 20-year follow-up of a case of limbal autograft stem cell transplantation due to LSCD secondary to chemical injury.

Keywords: Amniotic membrane; chemical injury; limbal stem cell deficiency; ocular surface reconstruction.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Right eye from which the limbal stem cells were taken from
Figure 2
Figure 2
Left eye follow up after 1 year with completely healed ocular surface with minimal vascularization and symblepharon as well as deep amblyopia (a). Full ocular motility without restriction and with good closure of the lids (b) and intact corneal surface with vascularization (c)

Similar articles

References

    1. Barraquer J, King JH, McTigue JW. The cornea world congress. Washington: Butterworths; 1965. p. 354.
    1. Kenyon KR, Tseng SC. Limbal autograft transplantation for ocular surface disorders. Ophthalmology. 1989;96:709–22. - PubMed
    1. Notara M, Alatza A, Gilfillan J, Harris AR, Levis HJ, Schrader S, et al. In sickness and in health:Corneal epithelial stem cell biology, pathology and therapy. Exp Eye Res. 2010;90:188–95. - PubMed
    1. Kruse FE. Classification of ocular surface disease. In: Holland EJ, Mannis MJ, editors. Ocular Surface Disease:Medical and Surgical Management. New York (NY): Springer; 2002. pp. 16–36.
    1. Cursiefen C. Immune privilege and angiogenic privilege of the cornea, Chem. Immunol. Allergy. 2007;92:50–7. - PubMed

Publication types